EXPRESSION ANALYSIS OF CANONICAL WNT PATHWAY GENES IN ORAL SQUAMOUS CELL CARCINOMA AND THEIR POSSIBLE ROLE AS BIOMARKERS

Author(s):  
MADHULAXMI MARIMUTHU ◽  
P.U. ABDUL WAHAB ◽  
ANANDAN BALAKRISHNAN ◽  
SAMBANDHAM SHANMUGAM ◽  
VINOD NARAYANAN ◽  
...  
2018 ◽  
Vol 29 (3) ◽  
pp. 291 ◽  
Author(s):  
Madhulaxmi Marimuthu ◽  
Manoharan Andiappan ◽  
Abdul Wahab ◽  
MR Muthusekhar ◽  
Anandan Balakrishnan ◽  
...  

2008 ◽  
Vol 2 ◽  
pp. CMO.S612 ◽  
Author(s):  
Eric H.L. Lee ◽  
Raj Chari ◽  
Andy Lam ◽  
Raymond T. Ng ◽  
John Yee ◽  
...  

Disruptions of beta-catenin and the canonical Wnt pathway are well documented in cancer. However, little is known of the non-canonical branch of the Wnt pathway. In this study, we investigate the transcript level patterns of genes in the Wnt pathway in squamous cell lung cancer using reverse-transcriptase (RT)-PCR. It was found that over half of the samples examined exhibited dysregulated gene expression of multiple components of the non-canonical branch of the WNT pathway. In the cases where beta catenin ( CTNNB1) was not over-expressed, we identified strong relationships of expression between wingless-type MMTV integration site family member 5A ( WNT5A)/ frizzled homolog 2 ( FZD2), frizzled homolog 3 ( FZD3)/ dishevelled 2 ( DVL2), and low density lipoprotein receptor-related protein 5 ( LRP5)/ secreted frizzled-related protein 4 ( SFRP4). This is one of the first studies to demonstrate expression of genes in the non-canonical pathway in normal lung tissue and its disruption in lung squamous cell carcinoma. These findings suggest that the non-canonical pathway may have a more prominent role in lung cancer than previously reported.


2020 ◽  
Vol 17 (2) ◽  
pp. 67-72
Author(s):  
Aika Tanzawa ◽  
Masashi Shiiba ◽  
Tomoaki Saito ◽  
Atsushi Kasamatsu ◽  
Yosuke Endo‐Sakamoto ◽  
...  

Animals ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 1615
Author(s):  
Barbora Putnová ◽  
Iveta Putnová ◽  
Miša Škorič ◽  
Marcela Buchtová

The Wnt signaling pathway is well known to be involved in many types of human cancer; however, in veterinary medicine, the investigation of individual Wnt members’ expression, and their role in or association with oral tumor pathogenesis, is still underevaluated. We aim to determine the expression pattern of Frizzled-6 (FZD6) as one of the Wnt receptors in two of the most common canine oral neoplastic lesions—canine oral squamous cell carcinoma (COSCC) and canine acanthomatous ameloblastoma (CAA). While COSCC is a malignant tumor with aggressive biological behavior and a tendency to metastasize, CAA is a benign tumor with high local invasiveness. In CAA, the expression of FZD6 was mostly located in the center of the epithelial tumorous tissue, and cells exhibiting features of squamous metaplasia were strongly positive. In well-differentiated COSCC, FZD6 was expressed in the tumorous epithelium as well as the tumorous stroma. There was a negative correlation between cytokeratin expression and FZD6 expression in COSCC, where the central parts of the epithelial tumorous tissue were often FZD6-negative. The non-differentiated COSCC with low expression of cytokeratin exhibited a diffuse FZD6 signal. The invasive front with areas of tumor budding exhibited high FZD6 expression with a loss of cytokeratin expression. Moreover, the expression of β-catenin and AXIN2 was increased in comparison to gingiva. In conclusion, our study revealed significant differences in the expression patterns and the levels of FZD6 between COSCC and CAA, indicating the differential engagement of the Wnt pathway in these tumors.


Sign in / Sign up

Export Citation Format

Share Document